Author: OurCrowd

[NanoLock in NanoLock Security] NanoLock and Renesas partner to safeguard smart meters

Hod Hasharon, Israel – September 14, 2022 – NanoLock Security, a leading device-level cybersecurity provider for smart meters and IIoT devices, and Renesas Electronics Corp., a prominent global semiconductor manufacturer, today announce a partnership to introduce a new platform that will further secure Renesas’ customers’ smart meters from cyber-attacks. The joint solution from the Israeli cybersecurity company and the Japanese microcontroller unit (MCU) maker will be available to all Renesas customers, including many of the world’s leading smart meter manufacturers. Read...

Read More

[Nexa3D in Business Wire] Nexa3D announces professional series upgrade for its flagship, ultrafast 3d printers

VENTURA, Calif.–(BUSINESS WIRE)–Nexa3D, the maker of ultrafast industrial polymer 3D printers, today announced the immediate availability of its new Professional Series upgrade for its flagship NXE series printers. Based on Nexa3D’s ultrafast LSPc technology, the Pro Series delivers higher productivity and part accuracy with greater print success. The Pro Series opens the materials aperture to accommodate broader polymer options including higher viscosity resins for industrial users who demand the highest print accuracy, repeatability, and volume production yields. Read...

Read More

[Freightos in PR Newswire] Freightos Limited and Gesher I Acquisition Corp. announce confidential submission of F-4 registration statement for proposed business combination

JERUSALEM, Sept. 13, 2022 /PRNewswire/ — Gesher I Acquisition Corp. (NASDAQ: GIAC, “Gesher”) a publicly-traded special purpose acquisition company, and Freightos Limited (“Freightos” or the “Company”), today announced the confidential submission to the U.S. Securities and Exchange Commission (“SEC”) of a draft registration statement on Form F-4 (the “Registration Statement”) relating to their previously announced proposed business combination. Read...

Read More

[Insightec in Business Wire] SonALAsense forges ahead with first patient dosing for devastating childhood brain cancer

OAKLAND, Calif.–(BUSINESS WIRE)–Diffuse intrinsic pontine glioma (DIPG) is a rare and deadly pediatric brain cancer with a 2% five-year survival rate. To provide therapeutic options for patients and families, SonALAsense is partnering with clinicians at Children’s National Hospital, Ivy Brain Tumor Center at Barrow Neurological Institute, Phoenix Children’s Hospital and University of California San Francisco (UCSF) Medical Center to conduct a phase 1/2 clinical trial for sonodynamic therapy (SDT). This is the first SDT trial for children. Read...

Read More